Business
Press Release Oct 04 2023
Strides Pharma Science Limited has informed the Exchange regarding a press release dated October 04, 2023, titled "Strides receives USFDA approval for Efavirenz, Emtricitabine & Tenofovir Disoproxil Fumurate tablets".
About this update from Strides Pharma Science Ltd
Strides Pharma Science Limited has informed the Exchange regarding a press release dated October 04, 2023, titled "Strides receives USFDA approval for Efavirenz, Emtricitabine & Tenofovir Disoproxil Fumurate tablets". View Attachment
View stock analysis, news, and events for Strides Pharma Science Ltd